Vivos Therapeutics, Inc.

VVOS

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001716166

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

22

−3 vs. Q1 2026
Total value $242.74K

View 13F holders

Superinvestors holding VVOS

0

None of the superinvestors held VVOS at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by VVOS insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jul 15, 20264:23 PM ET	Jun 30, 2026	Skaff Michael C10% Owner	PPurchaseCommon Stock · Derivative	+5.5M	$0.582	+$3.2M	2.75M	–	SEC
Apr 2, 20267:34 PM ET	Mar 31, 2026	Skaff Michael C and 1 other10% Owner	PPurchaseCommon Stock	+1.35M	$1.34	+$1.81M	1.35M	New position	SEC
Apr 2, 20267:34 PM ET	Mar 31, 2026	Skaff Michael C and 1 other10% Owner	PPurchaseCommon Stock · Derivative	+4M	$1.34	+$5.36M	1.78M	–	SEC
Jun 20, 2023	Jun 20, 2023	Huntsman Ronald KirkChief Executive Officer	PPurchaseCommon Stock	+14K	$0.53	+$7.42K	86.52K	+19.3%	SEC
Jun 20, 2023	Jun 15 – Jun 16, 2023	Huntsman Ronald KirkChief Executive Officer	PPurchaseCommon Stock	+15.02K	$0.5366	+$8.06K	72.52K	+26.1%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in VVOS at the end of Q2 2026.

Institutions holding VVOS in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
GEODE CAPITAL MANAGEMENT, LLC	85,001	$38.63K	0.00%	−10,542−11.0%	Reduced
IHT Wealth Management, LLC	76,736	$34.88K	0.00%	+35,675+86.9%	Added
VANGUARD CAPITAL MANAGEMENT LLC	60,629	$27.59K	0.00%	−212,700−77.8%	Reduced
COMMONWEALTH EQUITY SERVICES, LLC	42,500	$19.32K	0.00%	00.0%	Unchanged
National Asset Management, Inc.	38,066	$18.77K	0.00%	00.0%	Unchanged